Latest news https://www.adelaide.edu.au/saigenci/ en Professor Jose Polo appointed as EMBL Australia Scientific Head https://www.adelaide.edu.au/saigenci/news/list/2025/04/17/professor-jose-polo-appointed-as-embl-australia-scientific-head SAiGENCI's Professor Jose Polo has been appointed as the new Scientific Head of EMBL Australia. April 17 2025 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2025/04/17/professor-jose-polo-appointed-as-embl-australia-scientific-head SAiGENCI researcher awarded funding in latest MRFF round https://www.adelaide.edu.au/saigenci/news/list/2025/04/08/saigenci-researcher-awarded-funding-in-latest-mrff-round A SAiGENCI project using nanotechnology has received funding in the latest round of Medical Research Future Fund (MRFF) Early-to-Mid Career Researchers funding. April 8 2025 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2025/04/08/saigenci-researcher-awarded-funding-in-latest-mrff-round Lorne Cancer Conference 2025 https://www.adelaide.edu.au/saigenci/news/list/2025/04/08/lorne-cancer-conference-2025 The South Australian immunoGENomics Cancer Institute (SAiGENCI) and Adelaide Centre for Epigenetics (ACE) were well represented at the 37th annual Lorne Cancer Conference held from the 13th to 15th of February in Lorne, a coastal town on the Great Ocean Road in Victoria. April 8 2025 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2025/04/08/lorne-cancer-conference-2025 New role brings hope for SA cancer patients https://www.adelaide.edu.au/saigenci/news/list/2025/03/27/new-role-brings-hope-for-sa-cancer-patients Eradicating cancer from being a terminal disease to one we can successfully manage and treat is the holy grail of cancer research – and the grand vision of a new Molecular Cancer Pathology Fellow being co-funded by The Hospital Research Foundation Group. March 27 2025 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2025/03/27/new-role-brings-hope-for-sa-cancer-patients SAiGENCI researcher granted national health funding https://www.adelaide.edu.au/saigenci/news/list/2025/03/11/saigenci-researcher-granted-national-health-funding SAiGENCI research into using PROTACs for cancer treatments has been funded in the latest round of the National Health and Medical Research Council (NHMRC) Investigator Grants. March 11 2025 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2025/03/11/saigenci-researcher-granted-national-health-funding SAiGENCI researchers given a funding boost https://www.adelaide.edu.au/saigenci/news/list/2024/12/18/saigenci-researchers-given-a-funding-boost Researchers from the South Australian immunoGENomics Cancer Institute (SAiGENCI), based at the University of Adelaide, have been awarded funding to further their work in prostate and pancreatic cancers. December 18 2024 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2024/12/18/saigenci-researchers-given-a-funding-boost SAiGENCI researchers awarded funding through NHMRC program https://www.adelaide.edu.au/saigenci/news/list/2024/12/18/saigenci-researchers-awarded-funding-through-nhmrc-program Two SAiGENCI research groups are among nine from the Faculty of Health and Medical Sciences awarded funding through the latest round of the National Health and Medical Research Council (NHMRC) Ideas Grants. December 18 2024 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2024/12/18/saigenci-researchers-awarded-funding-through-nhmrc-program Developing the first drug for multi-organ radiation protection https://www.adelaide.edu.au/saigenci/news/list/2024/11/25/developing-the-first-drug-for-multi-organ-radiation-protection A pharmaceutical breakthrough at the University of Adelaide is showing promise in both multi-organ radiation protection and cancer treatment. November 25 2024 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2024/11/25/developing-the-first-drug-for-multi-organ-radiation-protection SAiGENCI supporter repairs bicycles to support prostate cancer research https://www.adelaide.edu.au/saigenci/news/list/2024/11/12/saigenci-supporter-repairs-bicycles-to-support-prostate-cancer-research Richard Dopheide’s younger brother was only 65 years old when his life was taken by cancer.  This tragedy was the motivating force behind Richard’s decision to repair and sell bicycles to raise funds for cancer research.  November 12 2024 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2024/11/12/saigenci-supporter-repairs-bicycles-to-support-prostate-cancer-research Meet our researchers: Dharmesh D Bhuva https://www.adelaide.edu.au/saigenci/news/list/2024/11/08/meet-our-researchers-dharmesh-d-bhuva Dr Dharmesh D Bhuva, Postdoctoral Research Fellow, South Australian ImmunoGENomics Cancer Institute (SAiGENCI). November 8 2024 a1095400 https://www.adelaide.edu.au/saigenci/news/list/2024/11/08/meet-our-researchers-dharmesh-d-bhuva